Dasatinib for the treatment of chronic myeloid leukemia: patient selection and special considerations.

Keskin D., Sadri S., Eskazan A. E.

Drug design, development and therapy, vol.10, pp.3355-3361, 2016 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 10
  • Publication Date: 2016
  • Doi Number: 10.2147/dddt.s85050
  • Journal Name: Drug design, development and therapy
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.3355-3361
  • Istanbul University Affiliated: Yes